Analytical Data
-
Gene name
CLSTN2
- Application
-
Alternative Names
CSTN2; CS2; CDHR13; Cadherin-Related Family Member 13; Alcadein-gamma
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9H4D0
-
Expression Region
Arg31~Gln271
-
Molecular Weight
36kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CLSTN2, or calsyntenin-2, is a member of the calsyntenin family of proteins, which are implicated in various neurobiological processes, including synaptic transmission and neuronal differentiation. The interest in CLSTN2 has grown due to its potential role in neurodevelopmental disorders and neurodegenerative diseases. Research has suggested that CLSTN2 interacts with other key proteins involved in synapse formation and maintenance, thus influencing neuronal communication and plasticity. Additionally, variations in the CLSTN2 gene have been associated with conditions such as autism spectrum disorder, drawing attention to its significance in understanding the molecular underpinnings of these disorders. The development of recombinant CLSTN2 protein allows for the exploration of its structure-function relationships, facilitating studies on its biochemical properties and interactions within neuronal contexts. Overall, investigating CLSTN2 and its recombinant forms offers valuable insights into both its physiological roles in the nervous system and its potential implications in pathology, with prospects for therapeutic interventions in related disorders.
